News & Updates

Show Multimedia Only

Atacicept for IgA nephropathy succeeds in phase III trial

25 Nov 2025 by

Treatment with the self-administered atacicept injectable yields a significant reduction in proteinuria in patients with IgA nephropathy, according to interim data from the phase III ORIGIN 3 trial.

Atacicept for IgA nephropathy succeeds in phase III trial

25 Nov 2025

Tirzepatide may reduce major kidney events in T2D patients with CVD, CKD

25 Nov 2025 by

The use of tirzepatide appears to reduce decline in kidney function, prevent albuminuria progression, and lower the risk of the composite kidney outcome compared with dulaglutide in patients with type 2 diabetes (T2D), atherosclerotic cardiovascular disease (ASCVD), and very high-risk chronic kidney disease (CKD), reports a study presented at Kidney Week 2025.

Tirzepatide may reduce major kidney events in T2D patients with CVD, CKD

25 Nov 2025

Semaglutide lowers kidney fat, improves glomerular haemodynamic in T2D patients with CKD

25 Nov 2025 by

Treatment with semaglutide helps reduce kidney fat and enhance glomerular haemodynamic in adult patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), as shown in the REMODEL trial.

Semaglutide lowers kidney fat, improves glomerular haemodynamic in T2D patients with CKD

25 Nov 2025

Mirikizumab beneficial in paediatric ulcerative colitis

25 Nov 2025

The humanised immunoglobulin G4 monoclonal antibody mirikizumab appears to be safe and efficacious in the treatment of children with moderately to severely active ulcerative colitis, according to a phase II study.

Mirikizumab beneficial in paediatric ulcerative colitis

25 Nov 2025

Genetic structures predict adverse response to chemotherapy in breast cancer patients

24 Nov 2025

Certain genetic structures among patients with breast cancer are associated with adverse response to chemotherapy, reports a recent study.

Genetic structures predict adverse response to chemotherapy in breast cancer patients

24 Nov 2025

Dalbavancin safe, effective in paediatric Gram-positive infections

23 Nov 2025

Consolidation treatment with dalbavancin appears safe and effective for the treatment of severe infections caused by Gram-positive microorganisms in children, suggests a study.

Dalbavancin safe, effective in paediatric Gram-positive infections

23 Nov 2025

ICI therapy safe to use in aggressive pituitary neuroendocrine tumours

22 Nov 2025

Treatment with immune checkpoint inhibitors (ICI) is safe and feasible in patients with aggressive pituitary neuroendocrine tumours (PNTs), a recent study has shown.

ICI therapy safe to use in aggressive pituitary neuroendocrine tumours

22 Nov 2025

Oseltamivir can keep children with flu out of the ICU

21 Nov 2025 by

Treatment with oseltamivir in children hospitalized with influenza helps prevent progression into a state requiring ICU admission and shorten the length of hospital stay, as shown in a US-based retrospective study.

Oseltamivir can keep children with flu out of the ICU

21 Nov 2025

SGLT2 inhibitors help prevent anaemia in patients with diabetes

21 Nov 2025

The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors resulted in a reduced prevalence of anaemia and decreased risk of hospitalizations due to anaemia relative to the use of dipeptidyl peptidase 4 (DPP4) inhibitors in patients with diabetes, reports a study.

SGLT2 inhibitors help prevent anaemia in patients with diabetes

21 Nov 2025

Prior herpes zoster vaccination mitigates long-term complications after infection

20 Nov 2025 by

For individuals who sustained herpes zoster infection, prior receipt of recombinant zoster vaccine appears to reduce the long-term risks of major adverse cardiovascular events, dementia, and death, according to a retrospective study.

Prior herpes zoster vaccination mitigates long-term complications after infection

20 Nov 2025

News & Updates

Filter by Specialty:

Specialty:

Atacicept for IgA nephropathy succeeds in phase III trial

Atacicept for IgA nephropathy succeeds in phase III trial

Tirzepatide may reduce major kidney events in T2D patients with CVD, CKD

Tirzepatide may reduce major kidney events in T2D patients with CVD, CKD

Semaglutide lowers kidney fat, improves glomerular haemodynamic in T2D patients with CKD

Semaglutide lowers kidney fat, improves glomerular haemodynamic in T2D patients with CKD

Mirikizumab beneficial in paediatric ulcerative colitis

Mirikizumab beneficial in paediatric ulcerative colitis

Genetic structures predict adverse response to chemotherapy in breast cancer patients

Genetic structures predict adverse response to chemotherapy in breast cancer patients

Dalbavancin safe, effective in paediatric Gram-positive infections

Dalbavancin safe, effective in paediatric Gram-positive infections

ICI therapy safe to use in aggressive pituitary neuroendocrine tumours

ICI therapy safe to use in aggressive pituitary neuroendocrine tumours

Oseltamivir can keep children with flu out of the ICU

Oseltamivir can keep children with flu out of the ICU

SGLT2 inhibitors help prevent anaemia in patients with diabetes

SGLT2 inhibitors help prevent anaemia in patients with diabetes

Prior herpes zoster vaccination mitigates long-term complications after infection

Prior herpes zoster vaccination mitigates long-term complications after infection